- Home
- PHAT vs MHD Comparison
PHAT vs MHD Comparison
Compare PHAT & MHD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHAT
- MHD
- Stock Information
- Founded
- PHAT 2018
- MHD N/A
- Country
- PHAT United States
- MHD United States
- Employees
- PHAT N/A
- MHD N/A
- Industry
- PHAT Biotechnology: Pharmaceutical Preparations
- MHD Investment Bankers/Brokers/Service
- Sector
- PHAT Health Care
- MHD Finance
- Exchange
- PHAT Nasdaq
- MHD Nasdaq
- Market Cap
- PHAT 727.5M
- MHD 592.9M
- IPO Year
- PHAT 2019
- MHD N/A
- Fundamental
- Price
- PHAT $9.45
- MHD $11.20
- Analyst Decision
- PHAT Strong Buy
- MHD
- Analyst Count
- PHAT 5
- MHD 0
- Target Price
- PHAT $16.40
- MHD N/A
- AVG Volume (30 Days)
- PHAT 1.7M
- MHD 124.9K
- Earning Date
- PHAT 08-07-2025
- MHD 01-01-0001
- Dividend Yield
- PHAT N/A
- MHD 4.16%
- EPS Growth
- PHAT N/A
- MHD N/A
- EPS
- PHAT N/A
- MHD N/A
- Revenue
- PHAT $81,859,000.00
- MHD N/A
- Revenue This Year
- PHAT $195.03
- MHD N/A
- Revenue Next Year
- PHAT $106.77
- MHD N/A
- P/E Ratio
- PHAT N/A
- MHD N/A
- Revenue Growth
- PHAT 3055.70
- MHD N/A
- 52 Week Low
- PHAT $2.21
- MHD $9.92
- 52 Week High
- PHAT $19.71
- MHD $12.18
- Technical
- Relative Strength Index (RSI)
- PHAT 60.80
- MHD 49.91
- Support Level
- PHAT $8.19
- MHD $11.13
- Resistance Level
- PHAT $9.76
- MHD $11.25
- Average True Range (ATR)
- PHAT 0.66
- MHD 0.07
- MACD
- PHAT -0.21
- MHD 0.01
- Stochastic Oscillator
- PHAT 54.58
- MHD 54.17
About PHAT Phathom Pharmaceuticals Inc.
Phathom Pharmaceuticals Inc operates as a clinical-stage biopharmaceutical company. The firm is focused on developing and commercializing novel treatments for gastrointestinal, or GI, diseases. Its product comprises vonoprazan, an oral small-molecule potassium competitive acid blocker medicine that blocks acid secretion in the stomach. Vonoprazan shows rapid, potent, and durable anti-secretory effects and has demonstrated clinical benefits in the treatment of gastroesophageal reflux disease, and in combination with antibiotics for the treatment of Helicobacter pylori infection.
About MHD Blackrock MuniHoldings Fund Inc.
Blackrock Muniholdings Fund Inc is a closed-end management investment company. The fund's objective is to provide shareholders with current income exempt from U.S. federal income taxes. The company invests in Transportation, Health, Utilities, Education, Housing, and other sectors.